MCCA
GILD icon

Mill Creek Capital Advisors’s Gilead Sciences GILD Stock Holding History

Mill Creek Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385K Sell
2,761
-18
-0.6% -$2.52K 0.01% 189
2025
Q4 		$341K Buy
2,779
+49
+2% +$5.96K 0.01% 197
2025
Q3 		$303K Buy
2,730
+149
+6% +$16.9K 0.01% 218
2025
Q2 		$286K Sell
2,581
-25
-1% -$2.66K 0.01% 220
2025
Q1 		$292K Buy
2,606
+25
+1% +$2.58K 0.01% 215
2024
Q4 		$238K Sell
2,581
-187
-7% -$16.8K 0.01% 241
2024
Q3 		$232K Sell
2,768
-225
-8% -$17.2K 0.01% 225
2024
Q2 		$205K Buy
+2,993
New +$200K 0.01% 247
2024
Q1 		– Sell
-3,666
Closed -$297K – 247
2023
Q4 		$297K Buy
3,666
+767
+26% +$59.7K 0.01% 193
2023
Q3 		$217K Sell
2,899
-537
-16% -$41.3K 0.01% 205
2023
Q2 		$265K Buy
3,436
+696
+25% +$55.5K 0.01% 204
2023
Q1 		$227K Sell
2,740
-16
-0.6% -$1.32K 0.01% 216
2022
Q4 		$237K Buy
+2,756
New +$218K 0.01% 199

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Mill Creek Capital Advisors's GILD Position: Q1 2026 in Review

Mill Creek Capital Advisors reduced its Gilead Sciences (GILD) stake by 0.65% in Q1 2026, selling an estimated $2.52K and leaving 2,761 shares worth $385K. The position accounts for 0.01% of the portfolio, ranked #189.

Mill Creek Capital Advisors first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mill Creek Capital Advisors held 2,761 shares of Gilead Sciences worth $385K as of Q1 2026.
  • Mill Creek Capital Advisors sold 18 Gilead Sciences shares in Q1 2026, an estimated $2.52K.
  • Gilead Sciences made up 0.01% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #189 holding.
  • Mill Creek Capital Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.